%0 Journal Article
%T Preclinical evaluation of Amblyomin-X, a Kunitz-type protease inhibitor with antitumor activity
%A Ana M. Chudzinski-Tavassi
%A Durvanei A. Maria
%A Giuliana G. Rondon
%A Jean G. Souza
%A Juliana M. Sciani
%A Mauricio B. Goldfeder
%A Rosemary V. Bosch
%A Sonia Elisabete A.L. Will
%J Archive of "Toxicology Reports".
%D 2019
%R 10.1016/j.toxrep.2018.11.014
%K Amblyomin-X
%K Kunitz-type inhibitor
%K Toxicity
%K Preclinical
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6298944/